{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T02:35:35Z","timestamp":1764729335309,"version":"3.46.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Start\u2011up Fund Project of Fujian Medical University","award":["2018QH1005"],"award-info":[{"award-number":["2018QH1005"]}]},{"name":"Fujian Province Education Research Project for Young and Middle-Aged Teachers","award":["JAT241039"],"award-info":[{"award-number":["JAT241039"]}]},{"name":"Joint Funds for the innovation of science and Technology, Fujian province","award":["2024Y9414"],"award-info":[{"award-number":["2024Y9414"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06517-5","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:21:57Z","timestamp":1761096117000},"page":"5695-5710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating bulk and single-cell transcriptome to identify novel gene markers for germinal center B cells (GCB) subtype of diffuse large B-cell lymphoma"],"prefix":"10.1007","volume":"104","author":[{"given":"Huxing","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saijun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duane","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Ao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"6517_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/hematolrep16010017","volume":"16","author":"A Argentiero","year":"2024","unstructured":"Argentiero A, Andriano A, Marziliano D, Desantis V (2024) Navigating lymphomas through BCR signaling and Double-Hit insights: overview. Hematol Rep 16:164\u2013178. https:\/\/doi.org\/10.3390\/hematolrep16010017","journal-title":"Hematol Rep"},{"key":"6517_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.seminhematol.2023.11.006","volume":"60","author":"LK Hilton","year":"2023","unstructured":"Hilton LK, Scott DW, Morin RD (2023) Biological heterogeneity in diffuse large B-cell lymphoma. Semin Hematol 60:267\u2013276. https:\/\/doi.org\/10.1053\/j.seminhematol.2023.11.006","journal-title":"Semin Hematol"},{"key":"6517_CR3","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.3390\/jcm12237376","volume":"12","author":"Eva Gonzalez Barca","year":"2023","unstructured":"Eva Gonzalez Barca (2023) Developing new strategies for relapsed\/refractory diffuse large B-Cell lymphoma. J Clin Med 12:7376\u20137376. https:\/\/doi.org\/10.3390\/jcm12237376","journal-title":"J Clin Med"},{"key":"6517_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503\u2013511. https:\/\/doi.org\/10.1038\/35000501","journal-title":"Nature"},{"key":"6517_CR5","doi-asserted-by":"publisher","first-page":"9991","DOI":"10.1073\/pnas.1732008100","volume":"100","author":"G Wright","year":"2003","unstructured":"Wright G, Tan B, Rosenwald A et al (2003) A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci 100:9991\u20139996. https:\/\/doi.org\/10.1073\/pnas.1732008100","journal-title":"Proc Natl Acad Sci"},{"key":"6517_CR6","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1182\/bloodadvances.2020001949","volume":"4","author":"ZY Xu-Monette","year":"2020","unstructured":"Xu-Monette ZY, Zhang H, Zhu F et al (2020) A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL. Blood Adv 4:3391\u20133404. https:\/\/doi.org\/10.1182\/bloodadvances.2020001949","journal-title":"Blood Adv"},{"key":"6517_CR7","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1200\/JCO.2014.60.2383","volume":"33","author":"DW Scott","year":"2015","unstructured":"Scott DW, Mottok A, Ennishi D et al (2015) Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies. J Clin Oncol 33:2848\u20132856. https:\/\/doi.org\/10.1200\/JCO.2014.60.2383","journal-title":"J Clin Oncol"},{"key":"6517_CR8","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36:1720\u20131748. https:\/\/doi.org\/10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"6517_CR9","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022019016","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood 140:1229\u20131253. https:\/\/doi.org\/10.1182\/blood.2022019016","journal-title":"Blood"},{"key":"6517_CR10","doi-asserted-by":"publisher","unstructured":"Scott DW (2015) Cell-of-Origin in diffuse large B-Cell lymphoma: are the assays ready for the clinic?? American society of clinic?al oncology educational book e. 458\u2013e466. https:\/\/doi.org\/10.14694\/edbook_am.2015.35.e458","DOI":"10.14694\/edbook_am.2015.35.e458"},{"key":"6517_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/bcp.14611","volume":"87","author":"K Ofori","year":"2020","unstructured":"Ofori K, Bhagat G, Rai AJ (2020) Exosomes and extracellular vesicles as liquid biopsy biomarkers in diffuse large B-cell lymphoma: current state of the art and unmet clinical needs. Br J Clin Pharmacol 87:284\u2013294. https:\/\/doi.org\/10.1111\/bcp.14611","journal-title":"Br J Clin Pharmacol"},{"key":"6517_CR12","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.3324\/haematol.2017.166827","volume":"102","author":"J-P Jais","year":"2017","unstructured":"Jais J-P, Molina TJ, Philippe, Ruminy et al (2017) Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay. Haematologica 102:e404\u2013e406. https:\/\/doi.org\/10.3324\/haematol.2017.166827","journal-title":"Haematologica"},{"key":"6517_CR13","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00428-022-03420-6","volume":"481","author":"A Zam\u00f2","year":"2022","unstructured":"Zam\u00f2 A, Gerhard-Hartmann E, Ott G et al (2022) Routine application of the Lymph2Cx assay for the subclassification of aggressive B-cell lymphoma: report of a prospective real-world series. Virchows Archiv: Int J Pathol 481:935\u2013943. https:\/\/doi.org\/10.1007\/s00428-022-03420-6","journal-title":"Virchows Archiv: Int J Pathol"},{"key":"6517_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/ajh.25666","volume":"95","author":"M Abdulla","year":"2019","unstructured":"Abdulla M, Hollander P, Tatjana, Pandzic et al (2019) Cell-of\u2010origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B\u2010cell lymphoma. Am J Hematol 95:57\u201367. https:\/\/doi.org\/10.1002\/ajh.25666","journal-title":"Am J Hematol"},{"key":"6517_CR15","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1182\/blood-2011-03-345272","volume":"118","author":"AA Alizadeh","year":"2011","unstructured":"Alizadeh AA, Gentles AJ, Alencar AJ et al (2011) Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment. Blood 118:1350\u20131358. https:\/\/doi.org\/10.1182\/blood-2011-03-345272","journal-title":"Blood"},{"key":"6517_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jmoldx.2015.01.007","volume":"17","author":"S Mareschal","year":"2015","unstructured":"Mareschal S, Ruminy P, Bagacean C et al (2015) Accurate classification of germinal center B-Cell\u2013Like\/Activated B-Cell\u2013Like diffuse large B-Cell lymphoma using a simple and rapid reverse Transcriptase\u2013Multiplex Ligation-Dependent probe amplification assay: A CALYM study. J Mol Diagn 17:273\u2013283. https:\/\/doi.org\/10.1016\/j.jmoldx.2015.01.007","journal-title":"J Mol Diagn"},{"key":"6517_CR17","doi-asserted-by":"publisher","unstructured":"He J, Chen Z, Xue Q et al (2022) Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature. J Translational Med 20. https:\/\/doi.org\/10.1186\/s12967-022-03393-9","DOI":"10.1186\/s12967-022-03393-9"},{"key":"6517_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/bib\/bbv064","volume":"17","author":"L Qi","year":"2015","unstructured":"Qi L, Chen L, Li Y et al (2015) Critical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer. Brief Bioinform 17:233\u2013242. https:\/\/doi.org\/10.1093\/bib\/bbv064","journal-title":"Brief Bioinform"},{"key":"6517_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/153303461000900204","volume":"9","author":"JA Eddy","year":"2010","unstructured":"Eddy JA, Sung J, Geman D, Price ND (2010) Relative expression analysis for molecular cancer diagnosis and prognosis. Technol Cancer Res Treat 9:149\u2013159. https:\/\/doi.org\/10.1177\/153303461000900204","journal-title":"Technol Cancer Res Treat"},{"key":"6517_CR20","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1755-8794-6-s1-s3","volume":"6","author":"H Wang","year":"2013","unstructured":"Wang H, Zhang H, Dai Z et al (2013) TSG: a new algorithm for binary and multi-class cancer classification and informative genes selection. BMC Med Genom 6:S3\u2013S3. https:\/\/doi.org\/10.1186\/1755-8794-6-s1-s3","journal-title":"BMC Med Genom"},{"key":"6517_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.radonc.2020.10.011","volume":"155","author":"M Li","year":"2021","unstructured":"Li M, Chen H, He J et al (2021) A qualitative classification signature for post-surgery 5-fluorouracil-based adjuvant chemoradiotherapy in gastric cancer. Radiother Oncol 155:65\u201372. https:\/\/doi.org\/10.1016\/j.radonc.2020.10.011","journal-title":"Radiother Oncol"},{"key":"6517_CR22","doi-asserted-by":"publisher","first-page":"573787","DOI":"10.3389\/fgene.2020.573787","volume":"11","author":"Q Guan","year":"2021","unstructured":"Guan Q, Zeng Q, Jiang W et al (2021) A qualitative transcriptional signature for the risk assessment of precancerous c lesions. Front Genet 11:573787. https:\/\/doi.org\/10.3389\/fgene.2020.573787","journal-title":"Front Genet"},{"key":"6517_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.806727","volume":"9","author":"W Zheng","year":"2022","unstructured":"Zheng W, Zhang R, Huang Z et al (2022) A qualitative signature to identify TERT promoter mutant high-risk tumors in low-grade gliomas. Front Mol Biosci 9:806727. https:\/\/doi.org\/10.3389\/fmolb.2022.806727","journal-title":"Front Mol Biosci"},{"key":"6517_CR24","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.3390\/cancers14163957","volume":"14","author":"J Wu","year":"2022","unstructured":"Wu J, Lin Z, Ji D et al (2022) Metabolism-related gene pairs to predict the clinical outcome and molecular characteristics of early hepatocellular carcinoma. Cancers (Basel) 14:3957\u20133957. https:\/\/doi.org\/10.3390\/cancers14163957","journal-title":"Cancers (Basel)"},{"key":"6517_CR25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/liv.15828","volume":"44","author":"D Ji","year":"2024","unstructured":"Ji D, Lu S, Zhang H et al (2024) Bulk and single-cell transcriptome reveal the immuno\u2010prognostic subtypes and tumour microenvironment heterogeneity in HCC. Liver Int 44:979\u2013995. https:\/\/doi.org\/10.1111\/liv.15828","journal-title":"Liver Int"},{"key":"6517_CR26","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1177\/0962280218804269","volume":"28","author":"C Boschini","year":"2018","unstructured":"Boschini C, Andersen KK, Scheike TH (2018) Excess risk estimation for matched cohort survival data. Stat Methods Med Res 28:3451\u20133465. https:\/\/doi.org\/10.1177\/0962280218804269","journal-title":"Stat Methods Med Res"},{"key":"6517_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","volume":"37","author":"E Becht","year":"2018","unstructured":"Becht E, McInnes L, Healy J et al (2018) Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol 37:38\u201344. https:\/\/doi.org\/10.1038\/nbt.4314","journal-title":"Nat Biotechnol"},{"key":"6517_CR28","doi-asserted-by":"publisher","first-page":"10800","DOI":"10.1093\/nar\/gkab835","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC et al (2021) Correction to the STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res 49:10800\u201310800. https:\/\/doi.org\/10.1093\/nar\/gkab835","journal-title":"Nucleic Acids Res"},{"key":"6517_CR29","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/nejmoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW et al (2018) Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med 378:1396\u20131407. https:\/\/doi.org\/10.1056\/nejmoa1801445","journal-title":"N Engl J Med"},{"key":"6517_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3960\/jslrt.23007","volume":"63","author":"S Yamada","year":"2023","unstructured":"Yamada S, Oka Y, Muramatsu M, Hashimoto Y (2023) High-grade B-cell lymphoma with 11q aberrations: a single-center study. J Clin Exp Hematopathol 63:121\u2013131. https:\/\/doi.org\/10.3960\/jslrt.23007","journal-title":"J Clin Exp Hematopathol"},{"key":"6517_CR31","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3324\/haematol.2014.120048","volume":"100","author":"J Ding","year":"2015","unstructured":"Ding J, Dirks WG, Ehrentraut S et al (2015) BCL6 - regulated by ahr\/arnt and wild-type MEF2B - drives expression of germinal center markers MYBL1 and LMO2. Haematologica 100:801\u2013809. https:\/\/doi.org\/10.3324\/haematol.2014.120048","journal-title":"Haematologica"},{"key":"6517_CR32","doi-asserted-by":"publisher","unstructured":"Ma D, Ma Y, Ma Y et al (2022) Molecular subtyping of CD5\u2009+\u2009diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx. Front Oncol 12. https:\/\/doi.org\/10.3389\/fonc.2022.941347","DOI":"10.3389\/fonc.2022.941347"},{"key":"6517_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.beha.2017.10.006","volume":"31","author":"T Lackraj","year":"2018","unstructured":"Lackraj T, Goswami R, Kridel R (2018) Pathogenesis of follicular lymphoma. Best Pract Res Clin Haematol 31:2\u201314. https:\/\/doi.org\/10.1016\/j.beha.2017.10.006","journal-title":"Best Pract Res Clin Haematol"},{"key":"6517_CR34","doi-asserted-by":"publisher","first-page":"101443","DOI":"10.1016\/j.xcrm.2024.101443","volume":"5","author":"JE Krull","year":"2024","unstructured":"Krull JE, Wenzl K, Hopper MA et al (2024) Follicular lymphoma B cells exhibit heterogeneous transcriptional States with associated somatic alterations and tumor microenvironments. Cell Rep Med 5:101443\u2013101443. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101443","journal-title":"Cell Rep Med"},{"key":"6517_CR35","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41590-018-0181-4","volume":"19","author":"P Milpied","year":"2018","unstructured":"Milpied P, Inaki Cervera-Marzal M-L, Mollichella et al (2018) Human germinal center transcriptional programs are de-synchronized in B cell lymphoma. Nat Immunol 19:1013\u20131024. https:\/\/doi.org\/10.1038\/s41590-018-0181-4","journal-title":"Nat Immunol"},{"key":"6517_CR36","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.molcel.2019.10.031","volume":"77","author":"V Shukla","year":"2020","unstructured":"Shukla V, Halabelian L, Balagere S et al (2020) HMCES functions in the alternative End-Joining pathway of the DNA DSB repair during class switch recombination in B cells. Mol Cell 77:384\u2013394e4. https:\/\/doi.org\/10.1016\/j.molcel.2019.10.031","journal-title":"Mol Cell"},{"key":"6517_CR37","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.1093\/nar\/gkad246","volume":"51","author":"Y Sugimoto","year":"2023","unstructured":"Sugimoto Y, Masuda Y, Iwai S et al (2023) Novel mechanisms for the removal of strong replication-blocking HMCES- and thiazolidine-DNA adducts in humans. Nucleic Acids Res 51:4959\u20134981. https:\/\/doi.org\/10.1093\/nar\/gkad246","journal-title":"Nucleic Acids Res"},{"key":"6517_CR38","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cell.2018.10.055","volume":"176","author":"KN Mohni","year":"2019","unstructured":"Mohni KN, Wessel SR, Zhao R et al (2019) HMCES maintains genome integrity by shielding abasic sites in single-strand DNA. Cell 176:144-153e13. https:\/\/doi.org\/10.1016\/j.cell.2018.10.055","journal-title":"Cell"},{"key":"6517_CR39","doi-asserted-by":"publisher","unstructured":"Klanova M, Oestergaard MZ, Marek, Trneny et al (2019) Prognostic impact of natural killer cell count in follicular lymphoma and diffuse large B-cell lymphoma patients treated with immunochemotherapy. 25 25:4634\u20134643. https:\/\/doi.org\/10.1158\/1078-0432.ccr-18-3270","DOI":"10.1158\/1078-0432.ccr-18-3270"},{"key":"6517_CR40","doi-asserted-by":"publisher","first-page":"100036","DOI":"10.1074\/mcp.RA120.002119","volume":"20","author":"X Wen","year":"2021","unstructured":"Wen X, Song G, Hu C et al (2021) Identification of novel serological autoantibodies in Takayasu arteritis patients using HuProt arrays. Mol Cell Proteom 20:100036. https:\/\/doi.org\/10.1074\/mcp.RA120.002119","journal-title":"Mol Cell Proteom"},{"key":"6517_CR41","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/nejmoa055759","volume":"354","author":"SS Dave","year":"2006","unstructured":"Dave SS, Fu K, Wright GW et al (2006) Molecular diagnosis of Burkitt\u2019s lymphoma. N Engl J Med 354:2431\u20132442. https:\/\/doi.org\/10.1056\/nejmoa055759","journal-title":"N Engl J Med"},{"key":"6517_CR42","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1182\/blood.2022015451","volume":"140","author":"M Fujisawa","year":"2022","unstructured":"Fujisawa M, Nguyen TB, Abe Y et al (2022) Clonal germinal center B cells function as a niche for T-cell lymphoma. Blood 140:1937\u20131950. https:\/\/doi.org\/10.1182\/blood.2022015451","journal-title":"Blood"},{"key":"6517_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/imr.12860","volume":"296","author":"MA Mintz","year":"2020","unstructured":"Mintz MA, Cyster JG (2020) T follicular helper cells in germinal center B cell selection and lymphomagenesis. Immunol Rev 296:48\u201361. https:\/\/doi.org\/10.1111\/imr.12860","journal-title":"Immunol Rev"},{"key":"6517_CR44","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ni.2239","volume":"13","author":"J Cui","year":"2012","unstructured":"Cui J, Li Y, Zhu L et al (2012) Nlrp4 negatively regulates type i interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat Immunol 13:387\u2013395. https:\/\/doi.org\/10.1038\/ni.2239","journal-title":"Nat Immunol"},{"key":"6517_CR45","doi-asserted-by":"publisher","first-page":"E498","DOI":"10.1073\/pnas.1715118115","volume":"115","author":"L Lu","year":"2018","unstructured":"Lu L, Zhu F, Zhang M et al (2018) Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma. Proc Natl Acad Sci 115:E498\u2013E505. https:\/\/doi.org\/10.1073\/pnas.1715118115","journal-title":"Proc Natl Acad Sci"},{"key":"6517_CR46","doi-asserted-by":"publisher","unstructured":"Wang H, Xia L, Ching F, Yao et al (2022) NLRP4 negatively regulates type I interferon response and influences the outcome in anti-programmed cell death protein (PD)\u20101\/PD\u2010ligand 1 therapy. 113:838\u2013851. https:\/\/doi.org\/10.1111\/cas.15243","DOI":"10.1111\/cas.15243"},{"key":"6517_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02970-y","author":"J Peng","year":"2024","unstructured":"Peng J, Yang Q, Lei R et al (2024) Preferential activation of type I interferon-mediated antitumor inflammatory signaling by CuS\/MnO2\/diAMP nanoparticles enhances anti-PD-1 therapy for sporadic colorectal cancer. J Nanobiotechnol. https:\/\/doi.org\/10.1186\/s12951-024-02970-y","journal-title":"J Nanobiotechnol"},{"key":"6517_CR48","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1182\/bloodadvances.2022007360","volume":"7","author":"T Loveday","year":"2022","unstructured":"Loveday T, Gerben Duns, Rimsza LM et al (2022) Transformation of FL into DLBCL with a PMBL gene expression signature. Blood Adv 7:893\u2013899. https:\/\/doi.org\/10.1182\/bloodadvances.2022007360","journal-title":"Blood Adv"},{"key":"6517_CR49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3960\/jslrt.22046","volume":"63","author":"Akiko Miyagi Maeshima","year":"2023","unstructured":"Akiko Miyagi Maeshima (2023) Histologic transformation of follicular lymphoma: pathologists\u2019 viewpoint. J Clin Experimental Hematopathology 63:12\u201318. https:\/\/doi.org\/10.3960\/jslrt.22046","journal-title":"J Clin Experimental Hematopathology"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06517-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06517-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06517-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T02:30:56Z","timestamp":1764729056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06517-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["6517"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06517-5","relation":{},"ISSN":["1432-0584"],"issn-type":[{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study adhered to international research ethics standards. As no human\/animal subjects or clinical trials were involved, ethics approval and informed consent were exempt. Publicly available data requiring no ethical clearance were used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics"}}]}}